Here is a thought. If the split is 10 to 1, right now the price goes to 4.25. If the price is 20 to 1, the price goes to
9.50 is too high for this stock and would cause a fast market cap fall. I am not a Feurenstein fan, but he is right that stocks under 300 million just don't pass FDA muster....strange but true.
So APPA has to pick the right RS to not scare off holders. They could try to split the difference at 15 to 1 (which they might do), but again, it may cause a precipitous fall.
Final option. Buy shares and lift the price on low volume, then reverse split at 10 to 1.
A 10 to 1 split is already built in and would be a relief for most investors. The stock may not rally on the rs at 10/1, but the fall should be smaller and shorter lived. This will allow them to simultaneously work toward a 300 million market cap at the same time APPA (Heron) goes through the final FDA approval.
If Heron gets an expedited review, we should see the stock easily hit 300 million before the decision.
El stupido has spoken. The ratio of the RS doesnt matter you mentally challenged monkey. He is trying to cover his bases with this post!
This is going to skyrocket mark my words .
Dont lsn to douches like him!